Literature DB >> 24488776

Recent developments in experimental animal models of Henipavirus infection.

Barry Rockx1.   

Abstract

Hendra (HeV) and Nipah (NiV) viruses (genus Henipavirus (HNV; family Paramyxoviridae) are emerging zoonotic agents that can cause severe respiratory distress and acute encephalitis in humans. Given the lack of effective therapeutics and vaccines for human use, these viruses are considered as public health concerns. Several experimental animal models of HNV infection have been developed in recent years. Here, we review the current status of four of the most promising experimental animal models (mice, hamsters, ferrets, and African green monkeys) and their suitability for modeling the clinical disease, transmission, pathogenesis, prevention, and treatment for HNV infection in humans.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  Henipavirus; animal model; pathogenesis

Mesh:

Year:  2014        PMID: 24488776     DOI: 10.1111/2049-632X.12149

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  12 in total

1.  Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster Model.

Authors:  Sarah C Genzer; Stephen R Welch; Florine E M Scholte; Jessica R Harmon; JoAnn D Coleman-McCray; Michael K Lo; Joel M Montgomery; Stuart T Nichol; Christina F Spiropoulou; Jessica R Spengler
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

2.  In Situ Imaging of Fluorescent Nipah Virus Respiratory and Neurological Tissue Tropism in the Syrian Hamster Model.

Authors:  Stephen R Welch; Florine E M Scholte; Jessica R Harmon; JoAnn D Coleman-McCray; Michael K Lo; Joel M Montgomery; Stuart T Nichol; Christina F Spiropoulou; Jessica R Spengler
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

3.  Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains.

Authors:  Alberto J Leon; Viktoriya Borisevich; Nahal Boroumand; Robert Seymour; Rebecca Nusbaum; Olivier Escaffre; Luoling Xu; David J Kelvin; Barry Rockx
Journal:  PLoS Negl Trop Dis       Date:  2018-03-14

4.  Livestock and Risk Group 4 Pathogens: Researching Zoonotic Threats to Public Health and Agriculture in Maximum Containment.

Authors:  Charles E Lewis; Bradley Pickering
Journal:  ILAR J       Date:  2022-01-07

5.  Vaccines to Emerging Viruses: Nipah and Hendra.

Authors:  Moushimi Amaya; Christopher C Broder
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

Review 6.  Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation.

Authors:  Gourapura J Renukaradhya; Balaji Narasimhan; Surya K Mallapragada
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

Review 7.  The Main Risk Factors of Nipah Disease and Its Risk Analysis in China.

Authors:  Jiarong Yu; Xinbo Lv; Zijun Yang; Shengbin Gao; Changming Li; Yumei Cai; Jinming Li
Journal:  Viruses       Date:  2018-10-19       Impact factor: 5.048

8.  Functional Analysis of the Fusion and Attachment Glycoproteins of Mojiang Henipavirus.

Authors:  Sofia Cheliout Da Silva; Lianying Yan; Ha V Dang; Kai Xu; Jonathan H Epstein; David Veesler; Christopher C Broder
Journal:  Viruses       Date:  2021-03-22       Impact factor: 5.048

9.  Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.

Authors:  Rebecca J Loomis; Anthony T DiPiazza; Samantha Falcone; Tracy J Ruckwardt; Kaitlyn M Morabito; Olubukola M Abiona; Lauren A Chang; Ria T Caringal; Vladimir Presnyak; Elisabeth Narayanan; Yaroslav Tsybovsky; Deepika Nair; Geoffrey B Hutchinson; Guillaume B E Stewart-Jones; Lisa A Kueltzo; Sunny Himansu; John R Mascola; Andrea Carfi; Barney S Graham
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

Review 10.  Emerging infections-an increasingly important topic: review by the Emerging Infections Task Force.

Authors:  E Petersen; N Petrosillo; M Koopmans
Journal:  Clin Microbiol Infect       Date:  2017-11-15       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.